Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: The disclosure discloses a method, device and system for sending configuration information. The method includes: a central controller respectively configures a parameter set for each of multiple forwarding devices, wherein the parameter set is used for establishing Security Associations (SA) between each pair of forwarding devices in the multiple forwarding devices; the central controller negotiates with the each of the multiple forwarding devices and creates one or more security channels between the central controller and the each of the multiple forwarding devices; and the central controller sends the parameter set to the each of the multiple forwarding devices through the one or more security channels. According to the technical solutions provided by the disclosure, complexity in establishment of SAs among the multiple forwarding devices is lowered, and data transmission security is improved.

Abstract: Provided are a method, apparatus and a cloud detection system for detecting a network device. The method includes that a detection packet library is created based on characteristic information and service configuration of a network device; characteristic information and service configuration of a to-be-detected network device are acquired; a detection packet is matched in the detection packet library according to the acquired characteristic information and service configuration of the to-be-detected network device, and the to-be-detected network device is detected by using the matched detection packet.

Abstract: Disclosed are a method, device, and computer storage medium for implementing IP address advertisement. An advertisement for controlling LSA11 and an advertisement control switch for flooding are added into a router. The router performs, according to a state indicated by the advertisement control switch, IP address advertisement or flooding for LSA11 encapsulated with an IP address.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: The embodiments of the present disclosure relate to an electrode structure and OLED display. The electrode structure includes a first electrode layer, a second electrode layer and a third electrode layer. The first electrode layer includes at least one layer from Ti layer, Ti alloy layer, Zr layer and Zr alloy layer. The second electrode layer is formed on the first electrode layer. The third electrode layer is formed on the second electrode layer and includes at least one layer from Ti layer, Ti alloy layer, Zr layer and Zr alloy layer. The present disclosure saves massive rare metal indium, which can help to reduce the manufacture cost of OLED display. Meanwhile, it is not prone to delamination, rupture, exfoliation and so on at the first and third electrode layers, and thusly reduced light scattering due to Ti, Ti alloy, Zr or Zr alloy with good corrosion resistance.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: An approach is provided for segmenting a cache into one or more cache segments and synchronizing the cache segments. An cache platform causes, at least in part, a segmentation of at least one cache into one or more cache segments. The cache platform further determines that at least one cache segment of the one or more cache segments is invalid. The cache platform also causes, at least in part, a synchronization of the at least one cache segment. The approach allows for a dynamic optimization of the synchronization of the cache segments based on one or more characteristics associated with the devices and/or the connection associated with the cache synchronization.

Abstract: A method of operation of an electronic system includes: capturing an image; recording an input associated with the image; capturing an updated image; and invoking an agent, with a control unit, associated with the updated image based on the input associated with the image.

Abstract: An alarm root cause analyzing method includes: obtaining at least one alarm of a managed network; sending an alarm raising time to a failed link locating device; receiving an identifier of a failed link, an identifier of an affected edge device, and an identifier of a device interface of the affected edge device; querying whether any alarm from the failed link exists in the at least one alarm, if an alarm from the failed link exists, marking the alarm from the failed link as a root cause alarm; querying whether any alarm from the affected edge device exists in the at least one alarm, if an alarm from the affected edge device exists, if a service object corresponding to the alarm from the affected edge device is borne over the device interface of the affected edge device, marking the alarm from the affected edge device as a derivative alarm.

Abstract: A system and method for managing, tracking and recording one or more biological process inputs, outputs and their derived forms is provided. The inputs pertaining to the biological process inputs, outputs and their derived forms are received and processed. The inputs include information related to the biological processes and the biological process inputs, outputs and their derived forms. The inputs further include information related to modifications in the biological process inputs, outputs and their derived forms. The inputs also include outputs of the biological processes. The inputs are processed by modifying the received inputs into a predefined format. Thereafter, the received inputs and processed inputs are stored. The stored inputs are accessed for managing, tracking and recording the biological processes, biological process inputs, outputs and their derived forms.

Abstract: A computing system includes a trait-recognition module configured to detect a physical identification signature for representing a user; a device-recognition module, coupled to the trait-recognition module, configured to detect a device-identification for representing a device closely associated with the user; and a connection module, coupled to the device-recognition module, configured to establish a device-grouping based on the physical identification signature for connecting the device with a further device for displaying a content on the device, the further device, or a combination thereof.

Abstract: The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Abstract: Wastewater treatment methods and systems for removal of phosphorus (P) and nitrogen (N) from wastewater and for recovery of them as usable materials. Sufficient amount of dolomite lime and slaked dolomite lime is added into the wastewater to increase the pH of the wastewater to above 8.5 and to form P precipitates and to convert ammonium to ammonia in a precipitation-ammonia stripping reactor or a continuous flow precipitation reactor. The P precipitates are separated from the wastewater and recovered as usable solid material. The ammonia gas is absorbed and concentrated with acid solution in an ammonia absorption tower as usable liquid material.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.

Abstract: A method of operation of a display system includes: providing a format; displaying content with the format configured to display on a display interface; receiving input based on the content displayed with the format on the display interface; and receiving input based on the content displayed with the format on the display interface.

Abstract: An electronic system includes: a control unit configured to select media based on a context factor for a media mix; and a display interface, coupled to the control unit, configured to display an adornment with the media mix on a device.

Abstract: Compounds are provided which are phosphonate and phosphinate activators and thus are useful in treating diabetes and related diseases and have the structure is a heteroaryl ring; R4 is —(CH2)n—Z—(CH2)m—PO(OR7)(OR8), —(CH2)nZ—(CH2)m—PO(OR7)R9, —(CH2)n—Z—(CH2)m—OPO(OR7)R9, —(CH2)nZ—(CH2)m—OPO(R9)(R10), or —(CH2)nZ—(CH2)m—PO(R9)(R10); R5 and R6 are independently selected from H, alkyl and halogen; Y is R7(CH2)s or is absent; and X, n, Z, m, R4, R5, R6, R7, and s are as defined herein; or a pharmaceutically acceptable salt thereof. A method for treating diabetes and related diseases employing the above compounds is also provided.

Abstract: The present invention is directed toward a monoclonal antibody to fibroblast growth factor receptor 2, a pharmaceutical composition comprising same, and methods of treatment comprising administering such a pharmaceutical composition to a patient.